International Biotechnology Trust’s Sutro Biopharma STRO Stock Holding History

International Biotechnology Trust’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,933	Closed	-$2.07M	–	79
2021 Q4	$2.07M	Hold	13,933	–	–	0.46%	45
2021 Q3	$2.63M	Hold	13,933	–	–	0.63%	35
2021 Q2	$2.59M	Hold	13,933	–	–	0.68%	34
2021 Q1	$3.17M	Hold	13,933	–	–	0.84%	27
2020 Q4	$3.01M	Hold	13,933	–	–	0.82%	26
2020 Q3	$1.4M	Hold	13,933	–	–	0.45%	33
2020 Q2	$1.1M	Hold	13,933	–	–	0.36%	40
2020 Q1	$1.38M	Hold	13,933	–	–	0.63%	28
2019 Q4	$1.53M	Hold	13,933	–	–	0.55%	39
2019 Q3	$1.26M	Sell	13,933 -582	-4%	-$58.8K	0.58%	32
2019 Q2	$1.64M	Sell	14,515 -150	-1%	-$16.5K	0.61%	39
2019 Q1	$1.67M	Hold	14,665	–	–	0.62%	41
2018 Q4	$1.05M	Hold	14,665	–	–	0.65%	33
2018 Q3	$1.69M	Buy	+14,665	New	+$2.21M	0.8%	34

Other funds holding STRO

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

International Biotechnology Trust's STRO Position: Q1 2022 in Review

International Biotechnology Trust sold out of Sutro Biopharma (STRO) in Q1 2022, closing a stake of 13,933 shares — an estimated $2.07M sold.

International Biotechnology Trust first reported a position in STRO in Q3 2018 and held it in 14 quarters. The position peaked at $3.17M in Q1 2021. 114 funds tracked by Wall St. Rank hold STRO as of Q1 2022.

International Biotechnology Trust reported no remaining Sutro Biopharma position as of Q1 2022 after selling out during the quarter.
International Biotechnology Trust sold 13,933 Sutro Biopharma shares in Q1 2022, an estimated $2.07M.
International Biotechnology Trust first reported a position in Sutro Biopharma in Q3 2018 and held it in 14 quarters.
International Biotechnology Trust's Sutro Biopharma position peaked at $3.17M in Q1 2021.
114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2022.

Based on International Biotechnology Trust's 13F filing for Q1 2022, filed 20 May 2022.